Diamox 250 mg tablets
*Company:
ADVANZ PharmaStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 14 September 2026
File name
1.3.1 SPC-Custom-SKP-Ireland-English-250mg.pdf
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
3 PHARMACEUTICAL FORM
Tablet
White, circular shallow biconvex tablets with quarter breakline on one side and embossed ‘FW’ and ‘147’ on other side.
White circular, biconvex tablet engraved with ‘FW’ and ‘147’ on one side and scored in quarters on the other.
Updated on 14 September 2026
File name
1.3.1 pil-QRD-Brand-Skyepharm- Custom-Ireland-english-250mg-Clean.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Free text change information supplied by the pharmaceutical company
DIAMOX are white, circular shallow biconvex tablets with quarter breakline on one side and embossed ‘FW’ and ‘147’ on other side.white circular, biconvex tablets engraved with “FW” and “147” on one side and scored in quarters on the other.
Updated on 07 January 2026
File name
1.3.1 SPC-Custom-SKP-Ireland-English-250mg.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 03 December 2025
File name
Diamox 250 mg Tablets_PIL.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 03 December 2025
File name
1.3.1 SPC-Custom-SKP-Ireland-English-250mg.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 18 December 2024
File name
Diamox 250 mg Tablets _PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 18 December 2024
File name
Diamox 250 mg Tablets _SPC.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 25 January 2024
File name
Diamox 250 mg Tablets_PIL.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 2 - excipient warnings
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 25 January 2024
File name
Diamox 250 mg Tablets_SPC.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
- Updated inline with QRD template and/or excipient guideline
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 22 December 2022
File name
DIAMOX_Acetazolamide 250mg Tablets_PIL_IE.pdf
Reasons for updating
- Change of manufacturer
Updated on 07 January 2022
File name
Diamox 250mg tablets_PIL_IE.pdf
Reasons for updating
- New PIL for new product
Updated on 07 January 2022
File name
Diamox 250mg tablets_SPC_IE.pdf
Reasons for updating
- Improved presentation of SPC
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 16 April 2019
File name
1.3.1_SPC-Custom-Chanelle-Ireland-English-250mg_9.0.pdf
Reasons for updating
- Change to section 8 - Marketing authorisation number(s)
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 16 April 2019
File name
1.3.1_SPC-Custom-Chanelle-Ireland-English-250mg_9.0.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
ADVANZ Pharma
Address:
Unit 17 Northwood House Northwood Crescent Northwood, Dublin 9, D09 V504, IrelandMedical Information E-mail:
medicalinformation@advanzpharma.comTelephone:
+44 (0)208 588 9131Website:
https://www.advanzpharma.comMedical Information Direct Line:
+353 1800 851 119Customer Care direct line:
+353 1 5294 230